Current gabapentinoid use in patients with inflammatory arthritis was associated with a 36% higher odds of fractures compared to remote use, with risks persisting across most dose levels and showing marked impact shortly after drug initiation.
A recent study published in JAMA Dermatology revealed the significant efficacy of nemolizumab in reducing pruritus and skin lesions in patients with moderate to severe prurigo nodularis.
A recent study identified two distinct pain phenotypes in patients with endometriosis, revealing significant differences in symptom severity, comorbidities, and quality of life.
A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.
The U.S. Food and Drug Administration issued draft guidance for drugmakers and medical device makers to improve diversity in clinical trials, emphasizing the importance of actions to support more equitable access to medical innovations.
A recent review published in JAMA Network Open reveals that both conventional and novel spinal cord stimulation therapies significantly outperformed conventional medical management in reducing chronic back and leg pain.